The Role of the Amyloid Protein Precursor (APP) in Alzheimer's Disease: Does the Normal Function of APP Explain the Topography of Neurodegeneration?

被引:0
|
作者
David H. Small
机构
[1] University of Melbourne,Laboratory of Molecular Neurobiology, Department of Pathology
来源
Neurochemical Research | 1998年 / 23卷
关键词
Alzheimer; dementia; amyloid; neurite; proteoglycan; plaque;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer's disease (AD) is the most common form of dementia in the aged population. Early-onset familial AD (FAD) involves mutations in a gene on chromosome 21 encoding the amyloid protein precursor or on chromosomes 14 or 1 encoding genes known as presenilins. All mutations examined have been found to increase the production of amyloidogenic forms of the amyloid protein (Aβ), a 4 kDa peptide derived from APP. Despite the remarkable progress in elucidating the biochemical mechanisms responsible for AD, little is known about the normal function of APP. A model of how APP and Aβ are involved in pathogenesis is presented. This model may explain why certain neuronal populations are selectively vulnerable in AD. It is suggested that those neurons which more readily undergo neuritic sprouting and synaptic remodelling are more vulnerable to Aβ neurotoxicity.
引用
收藏
页码:795 / 806
页数:11
相关论文
共 50 条
  • [1] The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration?
    Small, DH
    NEUROCHEMICAL RESEARCH, 1998, 23 (05) : 795 - 806
  • [2] β-secretase processing of the Alzheimer’s amyloid protein precursor (APP)
    Laura Marlow
    Melissa Cain
    Miguel A. Pappolla
    Kumar Sambamurti
    Journal of Molecular Neuroscience, 2003, 20 : 233 - 239
  • [3] β-secretase processing of the Alzheimer's amyloid protein precursor (APP)
    Marlow, L
    Cain, M
    Pappolla, MA
    Sambamurti, K
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (03) : 233 - 239
  • [4] Role of the APP promoter in Alzheimer's disease:: Cell type-specific expression of the β-amyloid precursor protein
    Lahiri, DK
    Ge, YW
    SIGNAL TRANSDUCTION PATHWAYS, CHROMATIN STRUCTURE, AND GENE EXPRESSION MECHANISMS AS THERAPEUTIC TARGETS, 2004, 1030 : 310 - 316
  • [5] The Role of TMP21 in Trafficking and Amyloid-β Precursor Protein (APP) Processing in Alzheimer's Disease
    Bromley-Brits, Kelley
    Song, Weihong
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (04) : 411 - 424
  • [6] Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease
    Schulte, Eva C.
    Fukumori, Akio
    Mollenhauer, Brit
    Hor, Hyun
    Arzberger, Thomas
    Perneczky, Robert
    Kurz, Alexander
    Diehl-Schmid, Janine
    Huell, Michael
    Lichtner, Peter
    Eckstein, Gertrud
    Zimprich, Alexander
    Haubenberger, Dietrich
    Pirker, Walter
    Bruecke, Thomas
    Bereznai, Benjamin
    Molnar, Maria J.
    Lorenzo-Betancor, Oswaldo
    Pastor, Pau
    Peters, Annette
    Gieger, Christian
    Estivill, Xavier
    Meitinger, Thomas
    Kretzschmar, Hans A.
    Trenkwalder, Claudia
    Haass, Christian
    Winkelmann, Juliane
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2015, 23 (10) : 1328 - 1333
  • [7] Novel polymorphisms of the amyloid precursor protein (APP) gene in Chinese/Taiwanese patients with Alzheimer's disease
    Thajeb, Peterus
    Wang, Pei
    Chien, Chung-Liang
    Harrigan, Rosanne
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (02) : 259 - 263
  • [8] Amyloid β and APP as biomarkers for Alzheimer's disease
    Zetterberg, Henrik
    Blennow, Kaj
    Hanse, Eric
    EXPERIMENTAL GERONTOLOGY, 2010, 45 (01) : 23 - 29
  • [9] Mutation of potential N-linked glycosylation sites in the Alzheimer's disease amyloid precursor protein (APP)
    Yazaki, M
    Tagawa, K
    Maruyama, K
    Sorimachi, H
    Tsuchiya, T
    Ishiura, S
    Suzuki, K
    NEUROSCIENCE LETTERS, 1996, 221 (01) : 57 - 60
  • [10] Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
    Al-kuraishy, Hayder M.
    Sulaiman, Ghassan M.
    Mohammed, Hamdoon A.
    Dawood, Retaj A.
    Albuhadily, Ali K.
    Al-Gareeb, Ali I.
    Abomughaid, Mosleh M.
    Klionsky, Daniel J.
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2025, 45 (01)